Vertex provided 2025 revenue guidance of $11.75 billion to $12 billion, reflecting 8% growth at the midpoint. Growth is expected from U.S. launches of ALYFTREK and JOURNAVX, along with the continued ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Shares of Monday.com (MNDY) soared intraday Monday after the project management software company guided for double-digit revenue growth in 2025 following stronger-than-expected fourth-quarter results.

While VTR's Q4 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, ...

Monday.com (MNDY) reported Q4 2024 revenue growth of 32% to $268M, beating estimates. Adjusted EPS of $1.08 also beat ...